Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GDC-1971 |
Trade Name | |
Synonyms | RLY1971|RLY 1971|RG-6433|RG6433|RLY-1971|GDC1971|GDC 1971 |
Drug Descriptions |
RLY-1971 is a selective SHP2 inhibitor, which potentially decreases tumor growth (PMID: 37774359). |
DrugClasses | SHP2 Inhibitor 20 |
CAS Registry Number | NA |
NCIT ID | C172988 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + GDC-1971 | Atezolizumab GDC-1971 | 0 | 1 |
Atezolizumab + GDC-1971 + Omeprazole | Atezolizumab GDC-1971 Omeprazole | 0 | 1 |
Cetuximab + GDC-1971 | Cetuximab GDC-1971 | 0 | 1 |
Divarasib + GDC-1971 | Divarasib GDC-1971 | 0 | 0 |
GDC-1971 | GDC-1971 | 0 | 1 |
GDC-1971 + Osimertinib | GDC-1971 Osimertinib | 0 | 1 |